Berger Franklin M Insider Trades & Stock Holdings

Director · Retension Pharmaceuticals, Inc. · Latest filing Oct 13, 2026

Berger Franklin M, Director at Retension Pharmaceuticals, Inc. has 1 Form 4 trade on file since Oct 13, 2026. Open-market activity: 1 purchase ($120K) and 0 sales ($0), net +$120K. Latest filing: acquired 10K shares of $RTSN on Oct 13, 2026 at $12.

Trades on file

1

Open-market bought

$120K

Open-market sold

$0

Net open-market

+$120K

Latest filing

Oct 13, 2026

All insider trades by Berger Franklin M

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 13, 2026	$RTSN	Buy (Open-market buy)	10K	$12	$120K						Director		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Berger Franklin M traded

• $RTSN

Frequently asked questions

Has Berger Franklin M been buying or selling stock?

Berger Franklin M has 1 open-market purchase and 0 open-market sales on file, net +$120K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Berger Franklin M's latest insider trade?

acquired 10K shares of $RTSN on Oct 13, 2026 at $12.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.